SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-011014
Filing Date
2024-03-22
Accepted
2024-03-22 17:17:15
Documents
77
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1940704
2 ex10-81.htm EX-10.81 61167
3 ex10-82.htm EX-10.82 32898
4 ex31-1.htm EX-31.1 18702
5 ex31-2.htm EX-31.2 19489
6 ex32.htm EX-32 10980
  Complete submission text file 0001493152-24-011014.txt   7834540

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bixt-20231231.xsd EX-101.SCH 57046
8 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bixt-20231231_cal.xml EX-101.CAL 51505
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bixt-20231231_def.xml EX-101.DEF 275116
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bixt-20231231_lab.xml EX-101.LAB 422494
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bixt-20231231_pre.xml EX-101.PRE 367943
80 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1121323
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35027 | Film No.: 24776226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)